Evidence map›Paper›PMID 30035021›Full record

ArticleNeuroImage. Clinical2018

Radiomics analysis allows for precise prediction of epilepsy in patients with low-grade gliomas.

Zhenyu Liu, Yinyan Wang, Xing Liu, Yang Du, Zhenchao Tang, Kai Wang, Jingwei Wei, Di Dong, Yali Zang, Jianping Dai and 2 more

Abstract read
In one paragraph

Article in NeuroImage. Clinical, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Morphometric and radiomics analysis toward the prediction of epilepsy associated with supratentorial low-grade glioma in children.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zhenyu LiuCAS Key Laboratory of Molecular Imaging, Institute of Automation, Beijing 100190, China.
Yinyan WangBeijing Tiantan Hospital, Capital Medical University, Beijing 100050, China; Beijing Neurosurgical Institute, Capital Medical University, Beijing 100050, China.
Xing LiuBeijing Tiantan Hospital, Capital Medical University, Beijing 100050, China; Beijing Neurosurgical Institute, Capital Medical University, Beijing 100050, China.
Yang DuCAS Key Laboratory of Molecular Imaging, Institute of Automation, Beijing 100190, China.
Zhenchao TangSchool of Mechanical, Electrical & Information Engineering, Shandong University, Weihai, Shandong Province 264209, China.
Kai WangBeijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.
Jingwei WeiCAS Key Laboratory of Molecular Imaging, Institute of Automation, Beijing 100190, China.
Di DongCAS Key Laboratory of Molecular Imaging, Institute of Automation, Beijing 100190, China.
Yali ZangCAS Key Laboratory of Molecular Imaging, Institute of Automation, Beijing 100190, China.
Jianping DaiBeijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.
Tao JiangBeijing Tiantan Hospital, Capital Medical University, Beijing 100050, China; Beijing Neurosurgical Institute, Capital Medical University, Beijing 100050, China. Electronic address: taojiang1964@163.com.
Jie TianCAS Key Laboratory of Molecular Imaging, Institute of Automation, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100080, China. Electronic address: jie.tian@ia.ac.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To investigate the association between imaging features and low-grade gliomas (LGG) related epilepsy, and to propose a radiomics-based model for the prediction of LGG-associated epilepsy. Methods: This retrospective study consecutively enrolled 286 patients with LGGs (194 in the primary cohort and 92 in the validation cohort). T2-weighted MR images (T2WI) were used to characterize risk factors for LGG-related epilepsy: Tumor location features and 3-D imaging features were determined, following which the interactions between these two kinds of features were analyzed. Elastic net was applied to generate a radiomics signature combining key imaging features associated with the LGG-related epilepsy with the primary cohort, and then a nomogram incorporating radiomics signature and clinical characteristics was developed. The radiomics signature and nomogram were validated in the validation cohort. Results: A total of 475 features associated with LGG-related epilepsy were obtained for each patient. A radiomics signature with eleven selected features allowed for discriminating patients with epilepsy or not was detected, which performed better than location and 3-D imaging features. The nomogram incorporating radiomics signature and clinical characteristics achieved a high degree of discrimination with area under receiver operating characteristic (ROC) curve (AUC) at 0.8769 in the primary cohort and 0.8152 in the validation cohort. The nomogram also allowed for good calibration in the primary cohort. Conclusion: We developed and validated an effective prediction model for LGG-related epilepsy. Our results suggested that radiomics analysis may enable more precise and individualized prediction of LGG-related epilepsy.

Indexed as

Brain NeoplasmsEpilepsyFemaleGliomaHumansMagnetic Resonance ImagingMaleModels, TheoreticalNeuroimagingNomogramsRetrospective StudiesRisk FactorsElastic netEpilepsyLow grade gliomasRadiomicsT2WI

Identifiers

PMID30035021
PMCPMC6051495

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.